|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0033325,
umls-concept:C0078058,
umls-concept:C0079441,
umls-concept:C0082420,
umls-concept:C0205179,
umls-concept:C0229671,
umls-concept:C0332281,
umls-concept:C0332293,
umls-concept:C0441889,
umls-concept:C0543467,
umls-concept:C0677886,
umls-concept:C1171892,
umls-concept:C1366583,
umls-concept:C1514162
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-5
|
|
pubmed:abstractText |
Serum CD105 has been associated with angiogenic activity in cancer, and low CD105 expression has been associated with improved prognosis. The present study evaluated the prognostic significance of serum levels of CD105 and related factors in patients with epithelial ovarian cancer (EOC) after cytoreductive surgery and chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/ENG protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/TGFB2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta2,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-54
|
|
pubmed:meshHeading |
pubmed-meshheading:20134268-Adult,
pubmed-meshheading:20134268-Aged,
pubmed-meshheading:20134268-Aged, 80 and over,
pubmed-meshheading:20134268-Antigens, CD,
pubmed-meshheading:20134268-Antineoplastic Agents,
pubmed-meshheading:20134268-Female,
pubmed-meshheading:20134268-Humans,
pubmed-meshheading:20134268-Middle Aged,
pubmed-meshheading:20134268-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:20134268-Ovarian Neoplasms,
pubmed-meshheading:20134268-Prognosis,
pubmed-meshheading:20134268-Receptors, Cell Surface,
pubmed-meshheading:20134268-Retrospective Studies,
pubmed-meshheading:20134268-Transforming Growth Factor beta2,
pubmed-meshheading:20134268-Vascular Endothelial Growth Factor A,
pubmed-meshheading:20134268-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article
|
